Viewing Study NCT01749969


Ignite Creation Date: 2025-12-24 @ 10:53 PM
Ignite Modification Date: 2026-01-02 @ 8:45 PM
Study NCT ID: NCT01749969
Status: COMPLETED
Last Update Posted: 2023-07-13
First Post: 2012-12-10
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: SAR650984 (Isatuximab), Lenalidomide, and Dexamethasone in Combination in RRMM Patients
Sponsor: Sanofi
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2013-02-06
Start Date Type: ACTUAL
Primary Completion Date: 2023-06-20
Primary Completion Date Type: ACTUAL
Completion Date: 2023-06-20
Completion Date Type: ACTUAL
First Submit Date: 2012-12-10
First Submit QC Date: None
Study First Post Date: 2012-12-17
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2023-07-12
Last Update Post Date: 2023-07-13
Last Update Post Date Type: ACTUAL